BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 33293522)

  • 1. A computational model for classification of BRCA2 variants using mouse embryonic stem cell-based functional assays.
    Biswas K; Lipton GB; Stauffer S; Sullivan T; Cleveland L; Southon E; Reid S; Magidson V; Iversen ES; Sharan SK
    NPJ Genom Med; 2020 Dec; 5(1):52. PubMed ID: 33293522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiological and ES cell-based functional evaluation of BRCA2 variants identified in families with breast cancer.
    Sullivan T; Thirthagiri E; Chong CE; Stauffer S; Reid S; Southon E; Hassan T; Ravichandran A; Wijaya E; Lim J; Taib NAM; Fadzli F; Yip CH; Hartman M; Li J; van Dam RM; North SL; Das R; Easton DF; Biswas K; Teo SH; Sharan SK; ;
    Hum Mutat; 2021 Feb; 42(2):200-212. PubMed ID: 33314489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequencing-based functional assays for classification of BRCA2 variants in mouse ESCs.
    Biswas K; Mitrophanov AY; Sahu S; Sullivan T; Southon E; Nousome D; Reid S; Narula S; Smolen J; Sengupta T; Riedel-Topper M; Kapoor M; Babbar A; Stauffer S; Cleveland L; Tandon M; Malys T; Sharan SK
    Cell Rep Methods; 2023 Nov; 3(11):100628. PubMed ID: 37922907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An integrative model for the comprehensive classification of BRCA1 and BRCA2 variants of uncertain clinical significance.
    Iversen ES; Lipton G; Hart SN; Lee KY; Hu C; Polley EC; Pesaran T; Yussuf A; LaDuca H; Chao E; Karam R; Goldgar DE; Couch FJ; Monteiro ANA
    NPJ Genom Med; 2022 Jun; 7(1):35. PubMed ID: 35665744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of the Clinical Relevance of BRCA2 Missense Variants by Functional and Computational Approaches.
    Guidugli L; Shimelis H; Masica DL; Pankratz VS; Lipton GB; Singh N; Hu C; Monteiro ANA; Lindor NM; Goldgar DE; Karchin R; Iversen ES; Couch FJ
    Am J Hum Genet; 2018 Feb; 102(2):233-248. PubMed ID: 29394989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional evaluation of BRCA2 variants mapping to the PALB2-binding and C-terminal DNA-binding domains using a mouse ES cell-based assay.
    Biswas K; Das R; Eggington JM; Qiao H; North SL; Stauffer S; Burkett SS; Martin BK; Southon E; Sizemore SC; Pruss D; Bowles KR; Roa BB; Hunter N; Tessarollo L; Wenstrup RJ; Byrd RA; Sharan SK
    Hum Mol Genet; 2012 Sep; 21(18):3993-4006. PubMed ID: 22678057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA repair-related functional assays for the classification of BRCA1 and BRCA2 variants: a critical review and needs assessment.
    Toland AE; Andreassen PR
    J Med Genet; 2017 Nov; 54(11):721-731. PubMed ID: 28866612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calibration of Pathogenicity Due to Variant-Induced Leaky Splicing Defects by Using
    Tubeuf H; Caputo SM; Sullivan T; Rondeaux J; Krieger S; Caux-Moncoutier V; Hauchard J; Castelain G; Fiévet A; Meulemans L; Révillion F; Léoné M; Boutry-Kryza N; Delnatte C; Guillaud-Bataille M; Cleveland L; Reid S; Southon E; Soukarieh O; Drouet A; Di Giacomo D; Vezain M; Bonnet-Dorion F; Bourdon V; Larbre H; Muller D; Pujol P; Vaz F; Audebert-Bellanger S; Colas C; Venat-Bouvet L; Solano AR; Stoppa-Lyonnet D; Houdayer C; Frebourg T; Gaildrat P; Sharan SK; Martins A
    Cancer Res; 2020 Sep; 80(17):3593-3605. PubMed ID: 32641407
    [No Abstract]   [Full Text] [Related]  

  • 9. Mis-splicing in breast cancer: identification of pathogenic BRCA2 variants by systematic minigene assays.
    Fraile-Bethencourt E; Valenzuela-Palomo A; Díez-Gómez B; Goina E; Acedo A; Buratti E; Velasco EA
    J Pathol; 2019 Aug; 248(4):409-420. PubMed ID: 30883759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Saturation genome editing of 11 codons and exon 13 of BRCA2 coupled with chemotherapeutic drug response accurately determines pathogenicity of variants.
    Sahu S; Sullivan TL; Mitrophanov AY; Galloux M; Nousome D; Southon E; Caylor D; Mishra AP; Evans CN; Clapp ME; Burkett S; Malys T; Chari R; Biswas K; Sharan SK
    PLoS Genet; 2023 Sep; 19(9):e1010940. PubMed ID: 37713444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GFP-Fragment Reassembly Screens for the Functional Characterization of Variants of Uncertain Significance in Protein Interaction Domains of the BRCA1 and BRCA2 Genes.
    Caleca L; Colombo M; van Overeem Hansen T; Lázaro C; Manoukian S; Parsons MT; Spurdle AB; Radice P
    Cancers (Basel); 2019 Jan; 11(2):. PubMed ID: 30696104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative Analysis of
    Farber-Katz S; Hsuan V; Wu S; Landrith T; Vuong H; Xu D; Li B; Hoo J; Lam S; Nashed S; Toppmeyer D; Gray P; Haynes G; Lu HM; Elliott A; Tippin Davis B; Karam R
    Front Oncol; 2018; 8():286. PubMed ID: 30101128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenicity evaluation of BRCA1 and BRCA2 unclassified variants identified in Portuguese breast/ovarian cancer families.
    Santos C; Peixoto A; Rocha P; Pinto P; Bizarro S; Pinheiro M; Pinto C; Henrique R; Teixeira MR
    J Mol Diagn; 2014 May; 16(3):324-34. PubMed ID: 24607278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of BRCA1 and BRCA2 splicing variants: a collaborative report by ENIGMA consortium members.
    Thomassen M; Blanco A; Montagna M; Hansen TV; Pedersen IS; Gutiérrez-Enríquez S; Menéndez M; Fachal L; Santamariña M; Steffensen AY; Jønson L; Agata S; Whiley P; Tognazzo S; Tornero E; Jensen UB; Balmaña J; Kruse TA; Goldgar DE; Lázaro C; Diez O; Spurdle AB; Vega A
    Breast Cancer Res Treat; 2012 Apr; 132(3):1009-23. PubMed ID: 21769658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In silico, in vitro and case-control analyses as an effective combination for analyzing BRCA1 and BRCA2 unclassified variants in a population-based sample.
    Rodríguez-Balada M; Roig B; Martorell L; Melé M; Salvat M; Vilella E; Borràs J; Gumà J
    Cancer Genet; 2016 Nov; 209(11):487-492. PubMed ID: 27886673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Saturation genome editing-based functional evaluation and clinical classification of BRCA2 single nucleotide variants.
    Huang H; Hu C; Na J; Hart SN; Gnanaolivu RD; Abozaid M; Rao T; Tecleab YA; Pesaran T; Lyra PCM; Karam R; Yadav S; Domchek SM; de la Hoya M; Robson M; Mehine M; Bandlamudi C; Mandelker D; Monteiro ANA; Boddicker N; Chen W; Richardson ME; Couch FJ
    bioRxiv; 2023 Dec; ():. PubMed ID: 38168194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The functional impact of variants of uncertain significance in BRCA2.
    Mesman RLS; Calléja FMGR; Hendriks G; Morolli B; Misovic B; Devilee P; van Asperen CJ; Vrieling H; Vreeswijk MPG
    Genet Med; 2019 Feb; 21(2):293-302. PubMed ID: 29988080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional classification of DNA variants by hybrid minigenes: Identification of 30 spliceogenic variants of BRCA2 exons 17 and 18.
    Fraile-Bethencourt E; Díez-Gómez B; Velásquez-Zapata V; Acedo A; Sanz DJ; Velasco EA
    PLoS Genet; 2017 Mar; 13(3):e1006691. PubMed ID: 28339459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional evaluation of five BRCA2 unclassified variants identified in a Sri Lankan cohort with inherited cancer syndromes using a mouse embryonic stem cell-based assay.
    Sirisena N; Biswas K; Sullivan T; Stauffer S; Cleveland L; Southon E; Dissanayake VHW; Sharan SK
    Breast Cancer Res; 2020 May; 22(1):43. PubMed ID: 32393398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic mRNA splicing assay for variants in
    Wangensteen T; Felde CN; Ahmed D; Mæhle L; Ariansen SL
    Hered Cancer Clin Pract; 2019; 17():14. PubMed ID: 31143303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.